Liquet Medical

Executive Summary

Liquet Medical is a private medical device company based in San Diego, California, founded in 2017 with a mission to transform vascular disease treatment through localized drug delivery. The company is reimagining vascular drug delivery, initially targeting pulmonary artery treatments. By focusing on patient outcomes and healthcare sustainability, Liquet aims to improve the efficacy and safety of therapies for vascular diseases, potentially reducing systemic side effects and improving quality of life. As a privately held entity, Liquet has not publicly disclosed funding, valuation, or pipeline details, indicating it may be in early stages of development, likely preclinical or early clinical. The company operates in the competitive medical device and drug delivery sectors, where innovation in localized delivery is a key trend. Despite limited public information, the company's focus on pulmonary artery treatments addresses a significant unmet need in conditions like pulmonary hypertension.

Upcoming Catalysts (preview)

• Q2 2026FDA IDE Submission for First-in-Human Study60% success
• Q3 2026Series A Funding Announcement70% success
• Q4 2026Publication of Preclinical Data80% success